deltatrials
Completed OBSERVATIONAL NCT03532126

A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit (PRIMAvera)

A Prospective, Multi-center, Non-comparative, 52-week Follow-up, Post-market Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit

Sponsor: Croma-Pharma GmbH

Updated 8 times since 2018 Last updated: Dec 6, 2024 Started: Mar 28, 2018 Primary completion: Jul 24, 2019 Completion: Jun 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Midface Volume Deficit, this trial is completed. The trial is conducted by Croma-Pharma GmbH and has accumulated 8 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotRecruiting~Sep 2018 – ~Jun 2020 · 21 months · monthly snapshotRecruiting~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshotUnknown Status~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotUnknown Status~Mar 2021 – ~Jul 2024 · 40 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotCompleted~Jan 2025 – present · 20 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Jan 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Jan 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Mar 2021 — Jul 2024 [monthly]

    Completed

    Status: Unknown StatusCompleted

  5. Jan 2021 — Mar 2021 [monthly]

    Unknown Status

Show 3 earlier versions
  1. Jun 2020 — Jan 2021 [monthly]

    Unknown Status

    Status: RecruitingUnknown Status

  2. Sep 2018 — Jun 2020 [monthly]

    Recruiting

  3. Jun 2018 — Sep 2018 [monthly]

    Recruiting

    First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Croma-Pharma GmbH
  • FGK Clinical Research GmbH
Data source: Croma-Pharma GmbH

For direct contact, visit the study record on ClinicalTrials.gov .